文献速递免疫规划

表达犬白细胞介素-6的重组狂犬病病毒增强免疫原性并可作为潜在疫苗

Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
PubMed 文献 · Vaccine · 2017-01-12

本研究拯救了表达犬白细胞介素-6(IL6)的重组狂犬病病毒(rHEP-CaIL6),并在小鼠中评估其致病性和免疫原性。单次肌内免疫后,rHEP-CaIL6组较亲本株组病毒中和抗体(VNA)和抗狂犬病病毒抗体出现更早、最高滴度更高;攻毒试验中存活率更高。流式细胞术显示rHEP-CaIL6免疫可招募成熟B细胞和CD8+ T细胞至淋巴结;鼻内感染rHEP-CaIL6的小鼠无临床症状,而亲本株组出现竖毛。作者认为表达犬IL6的重组狂犬病病毒可诱导强 protective 免疫应答且安全性良好,可能有助于开发有效、安全的减毒狂犬病疫苗。

要点

  • rHEP-CaIL6单次肌内免疫小鼠较亲本株诱导更早出现和更高滴度的VNA及抗RABV抗体。
  • 攻毒试验中rHEP-CaIL6免疫小鼠存活率高于亲本HEP-Flury免疫小鼠。
  • 鼻内感染rHEP-CaIL6的小鼠无临床症状,而HEP-Flury感染小鼠出现竖毛。

核心结论

  • rHEP-CaIL6可诱导强 protective 免疫应答且安全性良好,表达犬IL6的重组狂犬病病毒可能有助于开发有效、安全的减毒狂犬病疫苗。

研究设计与样本

  • 研究拯救了表达犬IL6的重组狂犬病病毒rHEP-CaIL6,并在小鼠中评估其致病性和免疫原性。

主要发现

  • 单次肌内免疫rHEP-CaIL6的小鼠较亲本株免疫小鼠显示更早出现和更高最大滴度的VNA及抗RABV抗体。
  • 攻毒试验中rHEP-CaIL6免疫小鼠存活率高于亲本HEP-Flury免疫小鼠。
  • 流式细胞术证实rHEP-CaIL6免疫诱导成熟B细胞和CD8+ T细胞强烈招募至淋巴结,可能部分解释高VNA水平和增强的细胞免疫。
  • 实时定量PCR显示rHEP-CaIL6在中枢神经系统诱导更强的炎症和免疫应答,可能有助于早期感染阶段清除病毒。
  • 鼻内感染rHEP-CaIL6的小鼠无临床症状,而感染HEP-Flury的小鼠出现竖毛。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several studies have confirmed that interleukin-6 (IL6) mediates multiple biological effects that enhance immune responses when used as an adjuvant. In the present study, recombinant rabies virus (RABV) expressing canine IL6 (rHEP-CaIL6) was rescued and its pathogenicity and immunogenicity were investigated in mice. We demonstrated that mice received a single intramuscular immunization with rHEP-CaIL6 showed an earlier increase and higher maximum titres of virus-neutralizing antibody (VNA) as well as anti-RABV antibodies compared with mice immunized with the parent strain. Moreover, survival rates of mice immunized with rHEP-CaIL6 were higher compared with mice immunized with parent HEP-Flury according to the challenge assay. Flow cytometry further confirmed that immunization with rHEP-CaIL6 induced the strong recruitment of mature B cells and CD8+ T cells to lymph nodes, which may partially explain the high levels of VNA and enhanced cellular immunity. Quantitative real-time PCR indicated that rHEP-CaIL6 induced stronger inflammatory and immune responses in the central nervous system, which might have allowed virus clearance in the early infection phase. Furthermore, mice infected intranasally with rHEP-CaIL6 developed no clinical symptoms while mice infected with HEP-Flury showed piloerection. In summary, these data indicate that rHEP-CaIL6 induces a strong, protective immune response with a good safety profile. Therefore, a recombinant RABV strain expressing canine IL6 may aid the development of an effective, safe attenuated rabies vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Luo J, Zhang B, Wu Y, et al. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine. Vaccine. 2017. PMID: 28089546. doi:10.1016/j.vaccine.2016.12.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。